That did not deter Kansas City, Kansas-based Aratana Therapeutics Inc. from announcing on Sept. 16 its aim to raise more than $41 million in its third public offering in less than 18 months. Four-year-old Aratana has already raised more than $200 million from public market investors since its June 2013 IPO.